Tempus AI (TEM) stock surged 13.4% on Thursday, hitting a new 52-week high of $86. The upside came after the health ...

Tempus AI (TEM) announced a new collaboration with the Institute for Follicular Lymphoma Innovation. The collaboration aims to develop and make ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...

Investors with a lot of money to spend have taken a bullish stance on Tempus AI TEM. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

Shareholders in Tempus AI, Inc. (NASDAQ:TEM) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts. The consensus estimated revenue numbers ...

In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other large-cap stocks. We previously covered 10 Large-Cap Stocks Insiders Are Buying Recently.

Tempus AI, Inc (NASDAQ:TEM) is soaring as investors get behind former House Speaker Nancy Pelosi's latest stock purchase. Yet, as we go through and discuss the setup here, I contend that investors ...

Tempus AI connects with over 2,500 institutions to collect real-time clinical data on millions of cancer patients. The company is able to use AI to derive diagnostic testing from this testing.

Tuesday, Tempus AI Inc (NASDAQ: TEM) received an Outperform rating from William Blair, as the firm initiated coverage on the company's stock. The positive outlook is ...

Tempus Ai got a big valuation boost following a disclosure that Nancy Pelosi had purchased call options for the stock. The healthcare AI company also unveiled its new software service today.